Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page now includes a funding note indicating 2019 U.S. NIH grant/contract support for the study. This adds funding context to the record.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAn updated revision tag Revision: v3.6.5 was added, and the Plain Language Summary along with the previous Revision: v3.6.4 tag were removed, updating the page's versioning and reducing the publicly visible plain-language overview.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page revision label has updated from v3.6.3 to v3.6.4, signaling a new version of the page content. No study details or outcomes are changed.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page shows a new revision label v3.6.3, replacing the previous v3.6.0. This indicates an update to the page version, but does not alter the study details or results.SummaryDifference0.0%

- Check75 days agoChange DetectedNew navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment header was added while the Intervention / Treatment header formatting was removed, with the revision label updated from v3.5.5 to v3.6.0. Additionally, the page now displays 'No longer looking for participants,' indicating that enrollment has ended.SummaryDifference0.1%

- Check82 days agoChange DetectedThe site’s revision metadata was updated from v3.5.4 to v3.5.5, signaling a new build of the page template. This update does not change the study data or content on the page.SummaryDifference0.0%

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.